CJC-1295 (No DAC) + Ipamorelin (5mg)
$45.00
— Free Shipping On Order $150+For Laboratory Research Only. Not for Human Consumption.
This product is intended solely for research purposes and complies with all applicable research chemical regulations.Buy More - Save More!
| Quantity | 3 | 4 - 6 | 6 - 10 |
|---|---|---|---|
| Discount | 5% | 10% | 15% |
| Price | $42.75 | $40.50 | $38.25 |
- ✔ GMP-grade handling & cold chain
- ✔ Tamper-evident vials, lot-tracked
- ✔ 24-hour email response
- ✔ Live status updates for tickets
CJC-1295 (No DAC) + Ipamorelin Blend Research Peptide | 99% Purity | Third Party Tested
Premium quality CJC-1295 No DAC + Ipamorelin blend research peptide with verified 99% purity, complete documentation, and fast USA shipping. Buy CJC-1295 Ipamorelin combination from a trusted laboratory supplier.
Why Researchers Choose Our CJC-1295 + Ipamorelin Blend
Our CJC-1295 (No DAC) + Ipamorelin blend research peptide represents the gold standard for synergistic growth hormone research requiring exceptional purity and documentation. Each vial is manufactured under GMP-aligned protocols with 99% purity verification, comprehensive third-party testing, and complete chain-of-custody documentation.
Key Trust Factors:
- Third-party tested and verified by independent laboratories
- USA manufactured under GMP-aligned procedures
- 99% purity with HPLC and MS verification
- Lot-matched COA included with every order
- Fast shipping with proper cold-chain handling
- Research-grade quality trusted by laboratories nationwide
What is CJC-1295 + Ipamorelin Blend? Complete Research Overview
The CJC-1295 (No DAC) + Ipamorelin blend represents the optimal combination of GHRH analog and selective GHRP for physiological growth hormone research. This combination leverages CJC-1295’s GHRH receptor activation with Ipamorelin’s selective ghrelin receptor agonism to create natural, pulsatile GH release patterns ideal for research applications.
Blend Components:
- CJC-1295 (No DAC): Modified GHRH(1-29) analog
- Ipamorelin: Selective growth hormone releasing peptide
Synergistic Mechanisms:
- Physiological GH pulsatility through dual pathway activation
- Enhanced amplitude of natural GH pulses
- Maintained circadian patterns without disruption
- Selective GH release without affecting other hormones
CJC-1295 + Ipamorelin Research Applications & Mechanisms
Primary Research Focus Areas:
1. Physiological GH Research Applications
The CJC-1295 + Ipamorelin combination research demonstrates optimal growth hormone release patterns that closely mimic natural physiology. Studies indicate this combination maintains natural GH pulsatility while enhancing amplitude, providing ideal research models for studying physiological growth hormone effects.
2. Sleep Research Studies
Laboratory studies show the combination enhances natural nocturnal GH release patterns and slow-wave sleep quality through synchronized GHRH and GHRP activation, providing insights into sleep-GH relationships and circadian rhythm research applications.
3. Anti-Aging Research Applications
Research indicates the blend affects age-related growth hormone decline through restoration of youthful GH secretion patterns, offering insights into aging mechanisms, hormone replacement strategies, and longevity research in experimental studies.
4. Body Composition Research Studies
Preclinical studies suggest the combination influences body composition through enhanced protein synthesis, improved lipolysis, and optimized metabolic rate while maintaining natural hormonal balance in various research applications.
Clinical Research & Scientific Studies
Combination Research Studies
A comprehensive study published in Growth Hormone and IGF Research examined the synergistic effects of CJC-1295 and Ipamorelin combination. Researchers found that the blend produced superior GH response compared to individual components while maintaining physiological patterns.
Study Results:
- 300% increase in GH pulse amplitude
- Maintained natural pulsatility patterns
- No disruption of other hormone systems
- Enhanced IGF-1 response
Sleep Research Findings
Research published in Sleep Medicine Reviews demonstrated the combination’s effects on sleep architecture, showing enhanced slow-wave sleep duration, improved sleep quality scores, correlation between GH release and sleep stages, and optimized nocturnal hormone patterns in research subjects.
Combination vs Individual Components: Research Comparison
| Property | CJC-1295 + Ipamorelin | Individual Components |
|---|---|---|
| GH Release Pattern | Physiological pulses | Variable |
| Hormone Selectivity | GH-specific | Component dependent |
| Side Effects | Minimal | Variable |
| Research Applications | Comprehensive | Specific |
| Efficacy | Synergistic | Individual |
Frequently Asked Questions (FAQ)
Q: Why combine CJC-1295 No DAC with Ipamorelin?
A: This combination produces the most physiological growth hormone release pattern by activating both GHRH and ghrelin receptors simultaneously, mimicking natural GH pulsatility while enhancing amplitude.
Q: How pure is your CJC-1295 + Ipamorelin blend?
A: Our blend exceeds 99% purity for each component as verified by HPLC and mass spectrometry, with complete analytical documentation provided with each batch.
Research Disclaimer & Legal Notice
Important Research Use Only Statement:
This CJC-1295 + Ipamorelin blend research peptide is supplied exclusively for in-vitro laboratory research and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or clinical application.
RUO disclaimer: For laboratory research use only. Not for human or veterinary consumption or therapeutic applications.
Certificate of Analysis (COA)
